Alkermes
ALKS
#3129
Rank
C$6.62 B
Marketcap
C$40.14
Share price
1.85%
Change (1 day)
-7.45%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): C$0.57 Billion

According to Alkermes's latest financial reports the company's current earnings are C$1.52 Billion. In 2024 the company made an earning of C$0.64 Billion a decrease over its 2023 earnings that were of C$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.57 B-11.23%
2024 C$0.64 B-17.97%
2023 C$0.78 B-468.52%
2022 -C$0.22 Billion449.24%
2021 -C$38.68 Million-68.04%
2020 -C$0.13 Billion-52.1%
2019 -C$0.26 Billion64.49%
2018 -C$0.16 Billion-15.04%
2017 -C$0.19 Billion-34.2%
2016 -C$0.28 Billion-5.34%
2015 -C$0.3 Billion35084.97%
2014 -C$0.83 Million
2012 C$10.22 M-117.81%
2011 -C$57.4 Million-12.69%
2010 -C$65.74 Million94.3%
2009 -C$33.84 Million-117.7%
2008 C$0.19 B622.63%
2007 C$26.45 M
2004 -C$0.11 Billion-14.48%
2003 -C$0.13 Billion11.88%
2002 -C$0.11 Billion39.65%
2001 -C$78.3 Million5.73%
2000 -C$74.06 Million-28.91%
1999 -C$0.11 Billion237.28%
1998 -C$30.89 Million100.05%
1997 -C$15.44 Million-37.93%
1996 -C$24.87 Million82.72%
1995 -C$13.62 Million-26.79%
1994 -C$18.59 Million-72.78%
1993 -C$68.31 Million208.07%
1992 -C$22.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-C$0.38 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.06 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.61 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.32 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.02 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$2.44 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-C$0.3 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.53 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
C$22.60 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland